Vaccination

Healio and Cardiology Today present highlights from the virtual American Heart Association Scientific Sessions, held Nov. 13 to 17.

On Monday, the FDA issued a statement reminding the public of the importance of following COVID-19 vaccine dosing schedules currently authorized by the agency.

Preprint data on the use of dexamethasone influenced clinical practice in treating patients with COVID-19 in Australia, researchers reported.

Data from the Colorado Immunization Information System showed a decrease in vaccination adherence among three separate age groups as a result of the pandemic.

In this episode, Gil Y. Melmed, MD, MS, joins us to discuss the available evidence regarding COVID-19 risk among patients with IBD, the pandemic’s effect on elective procedures, the future of telehealth for gastroenterologists and the importance of vaccination in these patients.

Most children and adolescents with HIV mounted antibody responses to the quadrivalent HPV vaccine, according to a study presented at IDWeek.

After decades of inactivity following a deadly vaccine failure in the 1960s, “there’s been good progress” lately in research to prevent respiratory syncytial virus, according to a speaker at the Infectious Diseases in Children symposium.

A vaccine candidate developed by Pfizer and BioNTech was more than 90% effective in preventing COVID-19 and showed no serious safety concerns, according to an interim analysis of phase 3 clinical trial results released by the companies.

Anthony S. Fauci, MD, director of the National Institutes of Allergy and Infectious Disease, told ACR Convergence 2020 meeting attendees that multiple vaccine candidates are “fully enrolled” in phase 3 trials in the U.S.

Customized web-based messages that provided new parents with vaccine information did not change their attitudes toward vaccines or positively impact infant vaccination, according to a randomized clinical trial.